Search results
Found 6794 matches for
Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.
Oxford Medicine December 2020
Oxford Medicine December 2020
Oxford Medicine Spring Summer 2021
Oxford Medicine Spring Summer 2021
Oxford Medicine Summer 2022
Oxford Medicine Summer 2022
Oxford Medicine Magazine - Winter 2023
Oxford Medicine Magazine - Winter 2023
Oxford Medicine Autumn Winter 2021
Oxford Medicine Autumn Winter 2021